Pidotimod | m-entrepreneurship.com

Product Name :
Pidotimod

Search keywords :
Pidotimod

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Immunostimulants

First Approval Country :
Mainland China

First Approval Date Filter:
2001

Origin Company_Name :

Active Company_Name :
Shenyang Shuangding Pharmaceutical Co Ltd

Active Indication_Name:
Respiratory Tract Infections

In Active Indication_Name:
Otitis Media

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cleaved PARP Antibody
Histone H3 (acetyl K27) Antibody
CHRNA9 Antibody: CHRNA9 Antibody is an unconjugated, approximately 55 kDa, rabbit-derived, anti-CHRNA9 polyclonal antibody. CHRNA9 Antibody can be used for: WB, IHC-P expriments in human, rat background without labeling.

Author: Betaine hydrochloride

Related Posts